PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Nov-2024 Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 Newswire
21-Nov-2024 Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 AccessWire
21-Nov-2024 APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived APONTIS PHARMA AG
21-Nov-2024 Panthera Biopartners now offers the broadest range of clinical trial therapy areas of any site management organisation in the UK Panthera Biopartners
21-Nov-2024 Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board with Appointments of World Class Veterans Vicebio
21-Nov-2024 NHS Trust’s missed opportunities to treat elderly woman’s pressure sore contributed to permanent nursing home move England’s Health Ombudsman
21-Nov-2024 First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach Pentixapharm Holding AG
21-Nov-2024 RNAConnect Partners With Bioz to Elevate Research Visibility AccessWire
21-Nov-2024 EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%. MPH Health Care AG
21-Nov-2024 NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Olympus
21-Nov-2024 Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025 Xlife Sciences AG
20-Nov-2024 Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies AccessWire
20-Nov-2024 Dr. Bill Releford and Los Angeles Rams Partner to Empower Community Health and Wellness AccessWire
20-Nov-2024 Model N Introduces GenAI and Intelligent Data Innovations to Market-Leading Revenue Optimization and Compliance Offering Model N
20-Nov-2024 Retinal Scanning Startup DeepEyeVision, Inc. is First in the World to Receive Validation from BSI's New AI Algorithm Audit and Dataset Testing Services DeepEyeVision
20-Nov-2024 KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles KOELIS
20-Nov-2024 STUDY LINKS RARE GENETIC MUTATION TO SEVERE NEUROLOGICAL DISORDER Karl Landsteiner University of Health Sciences
20-Nov-2024 Seaport Therapeutics Adds Sandi Peterson to its Board of Directors Seaport Therapeutics
20-Nov-2024 Mann Eye Institute First in Texas to Offer Revolutionary Glaucoma Treatment With Voyager DSLT AccessWire
20-Nov-2024 Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery Recursion